Interventional Cardiology Devices Market worth $ 25.61 Billion, Globally, by 2028 at 8.50% CAGR: Verified Market Research™

An upswing in the patient count of Diabetes and Coronary Artery Diseases, technological progress in the field of Interventional Cardiology Devices, increasing number of geriatric populations are the factors expected to positively impact the market.

News provided by

Verified Market Research

Jun 07, 2021, 09:15 ET

JERSEY CITY, N.J., June 7, 2021 /PRNewswire/ -- Verified Market Research recently published a report, "Interventional Cardiology Devices Market" By Product(Catheters, Plaque Modification Devices, Structural Heart Devices, Angioplasty Stents, Angioplasty Balloons, Hemodynamic Flow Alteration Devices and Other Devices), and By Geography. According to Verified Market Research, the Global Interventional Cardiology Devices Market was valued at USD 13.39 Billion in 2020 and is projected to reach USD 25.61 Billion by 2028, growing at a CAGR of 8.50% from 2021 to 2028.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=157618

Browse in-depth TOC on "Interventional Cardiology Devices Market"

202 - Pages
126 – Tables
37 – Figures

Global Interventional Cardiology Devices Market Overview

An important driver for growth of the Global Interventional Cardiology Devices market is the rise in the incidences of Coronary Artery Diseases. Coronary Artery Disease (CAD) is the most prevalent single cause of deaths and loss of Disability Adjusted Life Years (DALYs) around the world. CAD results in nearly 7 million deaths and 129 million DALYs per year. The increasing number of these diseases calls for effective ways for their treatment, which in turn is responsible for the expanding of Global Interventional Cardiology Devices Market. Another important growth driver is the rise in geriatric population around the world.

Growing number of people with diabetes is another factor for growth in the market, because diabetes is likely to play a part in the development of coronary heart diseases. According to the International Diabetes Federation, an estimated 463 million adults are living with diabetes in 2019, in comparison to the 425 million people in 2017. According to the United Nations there were 703 million people aged 65 and above worldwide in 2019. Such a high number of geriatric populations gives way for contracting a lot of heart diseases, and diabetes (especially of type 2) diseases which would require to be treated effectively, thus leading to a rise in the Global Interventional Cardiology Devices Market.

Key Developments in Interventional Cardiology Devices Market

In February 2021, iVascular announced the launch of new lengths for the Angiolite drug-eluting stent (DES) for the treatment of long lesions in the coronary arteries. The 44- and 49-mm lengths received the European CE Mark approval for the treatment of diffuse lesions.
In October 2020, Biosensors International Group Ltd announced European CE Mark approval for the company's new BioFreedom Ultra drug-coated coronary stent system.

The major players in the market are The major players in the market are Terumo Corporation (Japan), Biosensors International Group (Singapore), BIOTRONIK SE & Co. KG (Germany), Medtronic plc (Ireland), Boston Scientific Corporation (US), Abbott Laboratories (US), Edward Lifesciences Corporation (US), Cardinal Health, Inc. (US), iVascular (Spain), B. Braun Melsungen (Germany) among others.

Verified Market Research has segmented the Global Interventional Cardiology Devices Market On the basis of Product and Geography.

Interventional Cardiology Devices Market by Product

Catheters
Plaque Modification Devices
Structural Heart Devices
Angioplasty Stents
Angioplasty Balloons
Hemodynamic Flow Alteration Devices
Other Devices

Interventional Cardiology Devices Market by Geography

North America

U.S.
Canada
Mexico

Europe

Germany
France
U.K.
Rest of Europe

Asia Pacific

China
Japan
India
Rest of Asia Pacific

ROW

Middle East & Africa
Latin America

Browse Related Reports:

Interventional Cardiology and Peripheral Vascular Devices Market by Type (Angioplasty Balloons, Angioplasty Stents, Angioplasty Catheters, Endovascular Aneurysm Repair Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Accessories), by End User (Hospitals, Ambulatory Surgical Centers, and Others), by Geography, Forecast, 2020-2027

Cardiology Information Systems Market by Mode of Operation (Web-Based, On-Premises), by Component (Hardware, Software, Services), by End-User (Hospital Ambulatory Surgical Centers, Others), by Geography, Forecast, 2020-2027

Surgical Instruments Market by Product (Surgical Sutures and Staples, Handheld Surgical equipment, Electrosurgical Devices), by Application (Cardiology, Ophthalmology, Urology and Gynecology Surgery, Wound Care and Others), by Geography, Forecast, 2020-2027

Interventional Neuroradiology Market by Product (Cerebral Aneurysms, Intra-Cranial Tumors, Acute Strokes and Other Diseases), by Application (Hospital and Ambulatory Surgical Centers), by Geography, Forecast, 2020-2027

Top cardiac catheter sensor companies fueling the halted healthcare industry

Visualize Interventional Cardiology Devices Market using Verified Market Intelligence:-

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us:
Mr. Edwyne Fernandes
Verified Market Research
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: 1 (800)-782-1768
Email: [email protected]
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter